MODE D'ACTION BIOCHIMIQUE DU SULINDACLARGET PIET B; RECHNITZER A.1982; RHUMATOLOGIE (AIX-LES-BAINS); ISSN 0249-7581; FRA; DA. 1982; VOL. 34; NO 10; PP. 523-526Article

LIFE-THREATENING HYPERSENSITIVITY TO SULINDACSMITH FE; LINDBERG PJ.1980; J.A.M.A.; USA; DA. 1980; VOL. 244; NO 3; PP. 269-270; BIBL. 5 REF.Article

NEW DRUG EVALUATIONS. SULINDAC (CLINORIL^REG.-MSD)MILAP NAHATA.1979; DRUG INTELLIG. CLIN. PHARM.; USA; DA. 1979; VOL. 13; NO 12; PP. 736-740; BIBL. 35 REF.Article

DIE THROMBOZYTENFUNKTION UNTER DEM ANTIRHEUMATIKUM SULINDAC = EFFET DE L'ANTIRHUMATISMAL SULINDAC SUR LA FONCTION THROMBOCYTAIRESCHENK H; KLEIN G; NEUBAUER M et al.1980; WIEN. MED. WSCHR.; AUT; DA. 1980; VOL. 130; NO 10; PP. 344-349; ABS. ENG; BIBL. 21 REF.Article

SULINDAC-INDUCED ASEPTIC MENINGITISBALLAS ZK; DONTA ST.1982; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1982; VOL. 142; NO 1; PP. 165-166; BIBL. 9 REF.Article

COX inhibitors Indomethacin and Sulindac derivatives as antiproliferative agents: Synthesis, biological evaluation, and mechanism investigationCHENNAMANENI, Snigdha; BO ZHONG; LAMA, Rati et al.European journal of medicinal chemistry. 2012, Vol 56, pp 17-29, issn 0223-5234, 13 p.Article

CHOLESTATIC JAUNDICE CAUSED BY SULINDACGIROUX Y; MOREAU M; KASS TG et al.1982; CAN. J. SURG.; ISSN 0008-428X; CAN; DA. 1982; VOL. 25; NO 3; PP. 334-335; ABS. FRE; BIBL. 4 REF.Article

Green tea and cancer chemopreventionSUGANUMA, M; OKABE, S; SUEOKA, N et al.Mutation research. 1999, Vol 428, Num 1-2, pp 339-344, issn 0027-5107Conference Paper

MEMBRANE EFFECTS OF ANTIINFLAMMATORY AGENTS. I: INTERACTION OF SULINDAC AND ITS METABOLITES WITH PHOSPHOLIPID MEMBRANE, A MAGNETIC RESONANCE STUDYFAN SS; SHEN TY.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 10; PP. 1197-1202; BIBL. 17 REF.Article

UNUSUAL PERNIO-LIKE REACTION TO SULINDACREINERTSEN JL.1981; ARTHRITIS RHEUM.; ISSN 0004-3591; USA; DA. 1981; VOL. 24; NO 9; PP. 1215Article

ENTEROHEPATIC RECIRCULATION OF DRUGS AS A DETERMINANT OF THERAPEUTIC RATIODUGGAN DE; KWAN KC.1979; DRUG METABOL. RES.; USA; DA. 1979; VOL. 9; NO 1; PP. 21-41; BIBL. 21 REF.Conference Paper

HEPATOTOXICITE DE SULINDAC: A PROPOS DE QUATRE OBSERVATIONSBROCKER P; ROSSET M; SASSARD F et al.1983; PROVENCE (LA) MEDICALE; ISSN 513946; FRA; DA. 1983; VOL. 51; NO 1; PP. 35-36; BIBL. 9 REF.Article

SULINDAC (CLINORIL) HEPATITISARUN KUMAR DHAND; LABRECQUE DR; METZGER J et al.1981; GASTROENTEROLOGY; ISSN 0016-5085; USA; DA. 1981; VOL. 80; NO 3; PP. 585-586; BIBL. 12 REF.Article

DIFFERENT INTERACTIONS OF INDOMETHACIN AND SULINDAC WITH THIAZIDES IN HYPERTENSIONSTEINESS E; WALDORFF S.1982; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6356; PP. 1702-1703; BIBL. 3 REF.Article

HEPATITE AU SULINDAC: UNE OBSERVATION AVEC REVUE DES TROIS PRECEDENTESKAMMERER J; SABARDEIL S; RUMEAU JL et al.1982; GASTROENTEROL. CLIN. BIOL.; ISSN 0399-8320; FRA; DA. 1982; VOL. 6; NO 8-9; PP. 712-713; BIBL. 4 REF.Article

CLINORIL^REG. (SULINDAC): A CANADIAN MULTICENTRE STUDY IN PATIENTS WITH INFLAMMATORY JOINT DISEASEDAVIS P; KRIP G.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 30; NO 5 PART. 1; PP. 661-669; BIBL. 16 REF.Article

HEPATITIS ASSOCIATED WITH USE OF SULINDAC IN A CHILDADITYA KAUL; REDDY JC; FAGMAN E et al.1981; J. PEDIATR.; ISSN 0022-3476; USA; DA. 1981; VOL. 99; NO 4; PP. 650-651; BIBL. 8 REF.Article

MEMBRANE EFFECTS OF ANTIINFLAMMATORY AGENTS. II: INTERACTION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS WITH LIPOSOME AND PURPLE MEMBRANESSAN BAO HWANG; SHEN TY.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 10; PP. 1202-1211; BIBL. 33 REF.Article

HYPERTENSIVE REACTION WITH SULINDACEASTON PA; KOVAL A.1980; CANAD. MED. ASS. J.; CAN; DA. 1980; VOL. 122; NO 11; PP. 1273-1274; BIBL. 12 REF.Article

COMPUTERIZED MASS SPECTROMETRIC ASSAY FOR SULINDAC AND ITS METABOLITES IN HUMAN PLASMAWALKER RW; GRUBER VF; ROSENBERG A et al.1979; ANAL. BIOCHEM.; USA; DA. 1979; VOL. 95; NO 2; PP. 579-586; BIBL. 11 REF.Article

New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifenFUJIKI, Hirota; SUGANUMA, Masami; KURUSU, Miki et al.Mutation research. Fundamental and molecular mechanisms of mutagenesis. 2003, Vol 523-24, pp 119-125, issn 1386-1964, 7 p.Conference Paper

Effects of sulindac and indomethacin on the renin-aldosterone systemPEREZ, G. O; ALTMAN, R. D; FERNANDEZ, J. A et al.Current therapeutic research. 1985, Vol 38, Num 3, pp 507-512, issn 0011-393XArticle

ETUDE DU SULINDAC DANS LE TRAITEMENT DE L'ARTHROSE RACHIDIENNE: CERVICARTHROSE ET/OU LOMBARTHROSE (1800 OBSERVATIONS)RECHNITZER A.1981; GAZ. MED. FRANCE (1969); ISSN 0016-5557; FRA; DA. 1981; VOL. 88; NO 26; PP. 3743-3746; BIBL. 4 REF.Article

THE ROLE OF PHARMACOKINETICS IN DRUG PRODUCT DESIGNKWAN KC; HEIMLICH KR.1980; INT. J. PHARM.; ISSN 0378-5173; NLD; DA. 1980; VOL. 6; NO 3-4; PP. 225-241; BIBL. 26 REF.Article

KLINISCHE UNTERSUCHUNGEN MIT SULINDAC IN DER BEHANDLUNG DER PROGREDIENT-CHRONISCHEN POLYARTHRITIS = ETUDES CLINIQUES DU SULINDAC DANS LE TRAITEMENT DE LA POLYARTHRITE CHRONIQUE EVOLUTIVEPAVELKA K; VOJTISEK O; MALECEK J et al.1980; THERAPIEWOCHE; DEU; DA. 1980; VOL. 30; NO 17; PP. 3043-3049; (5 P.); BIBL. 11 REF.Article